DIA Announces 2011-2012 Board of Directors at DIA 2011

DIA today announced its 2011-2012 Board of Directors. The announcement came during DIA 2011 being held June 19-23 in Chicago, IL. The Board of Directors set the overall strategy for DIA activities.

Executive Committee:

• Dr. Yves Juillet, DIA President, LEEM, France
• Ling Su, DIA President-elect, Novartis Pharmaceuticals, China
• Dr. Richard Day, DIA Immediate-past President
• Minnie Baylor-Henry, DIA Treasurer, Johnson & Johnson Medical Devices & Diagnostics, USA
   

Directors:

• Michele Livesey, Livesey Consulting, USA
• Dr. Sandra Milligan, Amgen, USA
• Dr. Sandra L. Kweder, FDA, USA
• Dr. Steve Caffé, Medmmune, USA
• Truus Janse-de Hoog, Medicines Evaluation Board, The Netherlands
• Dr. Thomas Kühler, GE Healthcare Bio-Sciences, Sweden
• John A. Roberts, InfoLogix, USA
• Dr. Per Spindler, University of Copenhagen, Denmark
• Dr. Jean A Yager, BioPharm People, USA